Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The pharma sector wins, obviously
During a period of high demand and limited supply, the FDA allowed pharmacies to compound GLP-1s to help patients maintain access while manufacturers scaled up production
In a statement to CBS News Detroit, the company said it is ending coverage of GLP-1 drugs "for large group fully insured members beginning January 1, 2025, or on a group's 2025 health coverage renewal date." Additionally, the company said it will change prior authorization requirements for Saxenda, Wegovy and Zepbound beginning Aug
These include GLP-1 Daily Support and Weight Loss Boost
Dont layer with Vitamin C, AHAs, BHAs, or retinoids in the same routine
However, results are not guaranteed, can take several months to become visible, and require consistent treatment to maintain
